Alignment Healthcare (ALHC) president makes bona fide 4,200-share gift

Rhea-AI Filing Summary

Alignment Healthcare, Inc. president Dawn Christine Maroney reported a Form 4 showing a bona fide gift of 4,200 shares of common stock to family members on March 10, 2026. The transaction carried no sale price, and she now directly holds 992,815 shares after the gift.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maroney Dawn Christine

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		G(1)		4,200	D	$0	992,815	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents bona fide gifts to family members.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Alignment Healthcare (ALHC) report for Dawn Christine Maroney?

Alignment Healthcare president Dawn Christine Maroney reported a bona fide gift of 4,200 shares of common stock. The transaction was dated March 10, 2026 and was reported on a Form 4 insider filing as a non-sale, gift disposition.

How many Alignment Healthcare (ALHC) shares were transferred in this Form 4 gift?

The Form 4 shows a transfer of 4,200 shares of Alignment Healthcare common stock as a bona fide gift. The transaction price per share was reported as $0.0000, reflecting that this was a non-cash, gratuitous transfer rather than a market sale.

What is Dawn Christine Maroney’s role at Alignment Healthcare (ALHC) in this Form 4?

Dawn Christine Maroney is identified as an officer of Alignment Healthcare, serving as President. The reported transaction involves her direct holdings of common stock and is categorized as a bona fide gift, not a purchase or sale in the open market.

How many Alignment Healthcare (ALHC) shares does Dawn Christine Maroney hold after the gift?

Following the reported gift transaction, Dawn Christine Maroney directly holds 992,815 shares of Alignment Healthcare common stock. This post-transaction holding figure is provided in the Form 4 and reflects her remaining direct equity position after transferring 4,200 shares.

Who received the gifted Alignment Healthcare (ALHC) shares in this Form 4?

The footnote explains that the 4,200 Alignment Healthcare shares represent bona fide gifts to family members. This indicates the disposition was a personal transfer to relatives, with no sale proceeds or trading activity in the public market associated with the transaction.

Does the Alignment Healthcare (ALHC) Form 4 involve any derivative securities or option exercises?

The Form 4 transactions relate only to common stock and show no derivative securities, option exercises, or conversions. The derivativeSummary section is empty, indicating no reported activity in options, warrants, or other derivative instruments in this particular filing.